144 ·Filed Jun 26, 2026

KYMR

Kymera Therapeutics, Inc.
BEARISH
Impact 6/10
Horizondays Processed3mo ago SEC0000921895-26-001685
Form 144 — notice of proposed sale of securities
Actionable Insight ▼ Bearish

A $190M insider affiliate proposed sale is unusually large relative to recent insider activity. Monitor for actual execution on Form 4 — if completed, the increased float could pressure the stock near-term. Given Kymera's $9.6B market cap and 93% bullish analyst consensus, assess whether this is a liquidity-driven diversification by the fund or a signal of reduced conviction before the next catalyst (e.g., pipeline readout).

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
KYMR ▲ +11.65% at T+60d
SHORT call ✗ call lost -11.65% · α vs SPY -7.27% · entry $109.32 → $122.06
Entry anchored
Jun 26, 03:59 PM ET
via exchange tick
T+1d
+4.89%
call -4.89% · α -4.12%
$114.67
settled 3mo ago
T+5d
+4.98%
call -4.98% · α -3.59%
$114.76
settled 3mo ago
T+20d
+1.14%
call -1.14% · α -1.42%
$110.57
settled 2mo ago
T+60d
+11.65%
call -11.65% · α -7.27%
$122.06
settled 10d ago

Price Chart

Loading chart...

Executive Summary

BVF Partners L.P./IL, an affiliate of a Kymera Therapeutics director, filed a Form 144 on June 26, 2026, signaling intent to sell 1,630,658 shares of common stock. At a market value of approximately $189.9 million (based on a $116.47 share price from market cap data), this represents about 1.98% of Kymera's $9.6B market cap and is a large, material insider-level sale by a major institutional holder.

Key Facts

  • Reporting owner BVF Partners L.P./IL is an affiliate of a Kymera director
  • Proposed sale of 1,630,658 shares of common stock
  • Aggregate market value of approximately $189,906,430.68
  • Shares were originally acquired on March 11, 2020, and converted to common stock in the IPO on August 21, 2020
  • Sale to be conducted through Jefferies LLC on Nasdaq, dated June 26, 2026
  • Only 3 insider sells totaling $5.8M were reported in the prior 30 days; this filing dwarfs that activity

Financial Impact

Proposed sale of ~1.98% of outstanding shares valued at ~$189.9 million (calculated from 1,630,658 shares × $116.47 estimated price based on $9.6B market cap / 82,257,588 shares outstanding per filing)

dilutionownership concentrationfloat

Risk Factors

  • Potential near-term selling pressure if the entire block is executed quickly
  • Insider sale by a director-affiliated fund may be perceived as lack of confidence
  • Historical calibration shows score-6 reports on this filing type have a net negative expected alpha of -0.01% after costs, suggesting limited long-term edge

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (30 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0000921895-26-001685
Document: 0000921895-26-001685-index.html0000921895-26-001685
Document: 0000921895-26-001685.txt0000921895-26-001685
30 reports for KYMR
Performance horizon
73% Hit rate 8 of 11 directional calls best @ T+60▲ +60.99%Jun 8, 2026
Filters
Rows
Reports for KYMR — sortable, filterable
TypeNow
Aug 5, 2026
8w ago
8-K
BULLISH ★ 6/10
$105.48 $118.63▲ +12.47%▲ +13.07%$107.39 (+1.81%)
Jul 8, 2026
12w ago
Insider Cluster
BEARISH ★ 5/10
$114.16 $105.48▲ +7.60%▲ +10.88%$107.39 (+5.93%)
Jul 2, 2026
13w ago
Insider Cluster
BEARISH ★ 6/10
$113.51 $107.01▲ +5.73%▲ +5.31%$107.39 (+5.39%)
Jul 2, 2026
13w ago
Insider Cluster
BEARISH ★ 5/10
$113.51 $107.01▲ +5.73%▲ +5.31%$107.39 (+5.39%)
Jun 30, 2026
13w ago
144
BEARISH ★ 4/10
$114.20 $105.25▲ +7.84%▲ +5.65%$107.39 (+5.96%)
Jun 29, 2026
13w ago
144
NEUTRAL ★ 4/10
$114.67 $110.05▼ −4.03%▼ −3.00%$107.39 (−6.35%)
Jun 26, 2026
14w ago
Insider Cluster
BEARISH ★ 6/10
$109.32 $110.57▼ −1.14%▼ −1.42%$107.39 (+1.77%)
Jun 26, 2026
14w ago
144
BEARISH ★ 6/10
$109.32 $110.57▼ −1.14%▼ −1.42%$107.39 (+1.77%)
Jun 26, 2026
14w ago
144
BEARISH ★ 6/10
$109.32 $110.57▼ −1.14%▼ −1.42%$107.39 (+1.77%)
Jun 24, 2026
14w ago
144
NEUTRAL ★ 2/10
$116.46 $110.38▼ −5.22%▼ −5.75%$107.39 (−7.79%)
Showing 10 of 30

US Market Status

Market Closed — Opens Mon (38h 30m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access